Penicillin Allergy Delabeling Program: an exploratory economic evaluation in the Australian context

被引:9
|
作者
Brusco, Natasha K. [1 ,2 ]
Bury, Susan [3 ,4 ]
Chua, Kyra Y. L. [3 ]
Vogrin, Sara [5 ]
Holmes, Natasha E. [3 ,6 ,7 ,8 ]
Trubiano, Jason A. [3 ,9 ,10 ,11 ]
机构
[1] Monash Univ, Alpha Crucis Grp, Hlth Econ, Clayton, Vic, Australia
[2] Monash Univ, Rehabil Ageing & Independent Living RAIL Res Ctr, Clayton, Vic, Australia
[3] Austin Hlth, Dept Infect Dis, 145 Studley Rd, Heidelberg, Vic 3084, Australia
[4] Austin Hlth, Dept Pharm, Heidelberg, Vic, Australia
[5] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Med & Radiol, Melbourne, Vic, Australia
[7] Austin Hlth, Data Analyt Res & Evaluat DARE Ctr, Heidelberg, Vic, Australia
[8] Univ Melbourne, Melbourne, Vic, Australia
[9] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic, Australia
[10] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic, Australia
[11] Peter MacCallum Canc Ctr, Natl Ctr Infect Canc, Melbourne, Vic, Australia
关键词
Antibiotics; Delabeling; Health Economics; Health Service Research; COST-EFFECTIVENESS; HEALTH;
D O I
10.1111/imj.15532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Internationally, clinical and economic advantages of low-risk penicillin delabelling have been explored, supporting changes to healthcare delivery systems where penicillin delabelling is embedded into inpatient usual care. Aims To determine if economic advantages of low-risk inpatient penicillin delabelling, described in the international literature, are realised in the Australian context. Methods This explorative economic evaluation had prospective patient data collection between January and August 2019, across two Australian health services. Part 1: determine the cost per effectively delabelled patient for Penicillin Allergy Delabeling Program inpatients (PADP cohort) compared with Outpatient Antibiotic Allergy Testing Service outpatients (OAATS cohort). Part 2: a cost analysis to compare hospital costs for inpatients with low-risk penicillin allergy who did (PADP cohort) and did not (usual care cohort) undergo PADP delabelling. Results Part 1: the PADP (n = 350) and OAATS (n = 27 patients, n = 36 individual visits) cohorts were comparable. In PADP, costs/proportion delabelled was $20.10/0.98, equating to $20.51 per effectively delabelled patient; in OAATS, it was $181.24/0.50, equating to $362. Compared with OAATS, PADP was associated with savings of $341.97 per effectively delabelled patient, indicating the outpatient testing was the dominated strategy, being more costly and less effective. Part 2: the PADP (n = 218) and usual care (n = 32) cohorts were comparable. Significantly favouring the delabelled PADP cohort, the mean difference per patient was -4.41 days (95% confidence interval: -7.64, -1.18) and -$9467.72 (95% confidence interval: -$15 419.98, -$3515.46). Conclusions Consistent with international literature, delabelling low-risk penicillin allergies in the inpatient setting had economic advantages in the Australian context. Fully powered economic evaluations are urgently required to consolidate these findings.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 50 条
  • [41] Successful pediatric inpatient penicillin allergy delabeling through direct oral challenges
    Ray, Katie M.
    Vyles, David E.
    Zembles, Tracy N.
    Mitchell, Michelle L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (08): : 2193 - 2195
  • [42] Penicillin allergy delabeling in long-term care facilities: if not now, then when?
    Foong, Kap Sum
    Doron, Shira
    Wurcel, Alysse
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2025, 5 (01):
  • [43] Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study
    Trubiano, Jason A.
    Vogrin, Sara
    Copaescu, Ana
    Nasra, Mohamed
    Douglas, Abby
    Holmes, Natasha E.
    Chua, Kyra Y. L.
    ALLERGY, 2022, 77 (03) : 1038 - +
  • [44] LOW RISK INPATIENT PENICILLIN ALLERGY DELABELING BY THE NONALLERGIST PHYSICIAN, A PILOT STUDY
    Weaver, M.
    Huffman, J.
    Rice, L.
    Miller, N.
    Johnson, M.
    Hickey, S.
    Mense, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S13 - S14
  • [45] A Retrospective Critical Analysis and Risk Stratification of Penicillin Allergy Delabeling in a UK Specialist Regional Allergy Service
    Mohamed, Omar E.
    Beck, Sarah
    Huissoon, Aarnoud
    Melchior, Cathryn
    Heslegrave, Jane
    Baretto, Richard
    Ekbote, Anjali
    Krishna, Mamidipudi Thirumala
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (01): : 251 - 258
  • [46] The economic implications of penicillin allergy
    Parikh, Purvi
    Patel, Niraj C.
    Trogen, Brit
    Feldman, Eleanor
    Meadows, J. Allen
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (06) : 626 - 627
  • [47] Safe Penicillin Allergy Delabeling in Primary Care: A Systematic Review and Meta-Analysis
    Stul, Florian
    Heytens, Stefan
    Ebo, Didier Gaston
    Sabato, Vito
    Piessens, Veerle
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (09):
  • [48] Penicillin Allergy Testing and Delabeling for Patients Who Are Prescribed Penicillin: A Systematic Review for a World Health Organization Guideline
    Providencia, Rui
    Aali, Ghazaleh
    Zhu, Fang
    Leas, Brian F.
    Orrell, Rachel
    Ahmad, Mahmood
    Bray, Jonathan J. H.
    Pelone, Ferruccio
    Nass, Petra
    Marijon, Eloi
    Cassandra, Miryan
    Celermajer, David S.
    Shokraneh, Farhad
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2024, 66 (02) : 223 - 240
  • [49] A Retrospective Analysis of the Incidence of Allergy Relabeling in Patients who Underwent Penicillin Challenge and Delabeling
    Nassab, Caroline
    Moak, Rosemary
    Campbell, Emily
    Streck, Maria
    Williams, Kelli
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB169 - AB169
  • [50] A quality improvement initiative to improve primary care referral rates for penicillin allergy delabeling
    Wang, Helen
    Kozman, Maggie
    Pierce, Heather
    Ma, Lawrence
    Collins, Cathleen
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (01) : 33 - 38